Physician profile
Steve Hahn
NPI 1821084948
$11,358.32
in general payments reported to CMS, 2019-2025
16 companies · $2,216 in 2025
The $2,216 reported for 2025 was more than what 97% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $125 · 2021: $635 · 2022: $2,430 · 2023: $3,044 · 2024: $2,051 · 2025: $2,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,311.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,374.24 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,327.38 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $1,938.27 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Allergan, INC. | $882.48 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $636.26 | 2021-2023 | Ongentys |
| E.R. Squibb & Sons, L.L.C. | $513.57 | 2024-2025 | Cobenfy, Zeposia |
| Alkermes, INC. | $463.54 | 2022-2024 | Lybalvi |
| Kyowa Kirin, INC. | $249.95 | 2022-2023 | Nourianz |
| Vanda Pharmaceuticals INC. | $241.65 | 2024-2025 | Fanapt |
| Acadia Pharmaceuticals INC | $147.87 | 2022-2025 | Nuplazid |
| Kowa Pharmaceuticals America, INC. | $125.00 | 2022 | |
| Ani Pharmaceuticals, INC. | $124.75 | 2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $123.53 | 2024 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.40 | 2019 | |
| Biogen, INC. | $96.75 | 2024 | Vumerity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.